Innovate4Health

Selena is transforming eye care by leveraging AI to detect diseases like diabetic retinopathy with unprecedented accuracy, helping to diagnose issues early and prevent blindness, thus improving patient outcomes and offering more access globally.

TauRx is revolutionizing Alzheimer's treatment with a novel drug that targets toxic brain proteins, offering fresh hope in the fight against this devastating disease.

InCurA is revolutionizing MENA's medical landscape with AI-optimized, locally produced hemostatic solutions like CurASeal, bridging the gap between innovation and accessibility while reducing reliance on global imports.

Seven case studies showcase how IP rights are enabling innovators in Latin America to help solve some of the greatest global health challenges.

Twenty-five case studies underscore how innovators in developing countries—often enabled by robust IP rights—are achieving advances in life sciences and healthcare that benefit people around the world.

Previously, there were few HPV tests well suited to developing countries, but a new product—Xpert HPV—changes this by offering an accurate, real-time, self-contained, and easy to use molecular testing mechanism that can be used at the point-of-care.

The lack of alternative diagnostic options has become a major roadblock to getting more people with HIV on the path to treatment. But an innovative new product may finally do this.

Meet Arthur Zang, a 29 year-old Cameroonian engineer who invented the handheld Cardio-Pad, the world’s first medical tablet facilitating heart examinations and remote diagnosis. The Cardio-Pad is a touch-screen tablet device for conducting cardiac tests such as electrocardiograms in remote locations, and then sending the results to cardiologists in city centers often hundreds of miles away.

Rwanda’s government, which has declared a vision of making the country a technology and innovation hub for Africa, has partnered with the startup Zipline to facilitate the real-time delivery of urgent medical supplies, such as blood or vaccines, to patients in remote locations via drones.

NephroPlus’s story highlights the need for a broader focus on the barriers to healthcare, rather than accusing intellectual property of being the main culprit, as many in the debate around improving access to healthcare in developing countries have done, such as in the report by the United Nations High Level Panel on Access to Medicines.